All Reports Events Blogs Videos
Showing 49 results
  • Provider Compendium
    Nov. 28, 2025

    Everest Group’s Order-to-Cash (O2C) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 16 O2C products and includes insights on the global O2C products market. It examines each product’s features, enhancements, and market adoption…
  • PEAK Matrix®
    Sep. 19, 2025

    Enterprises are leveraging Employer of Record (EoR) solutions to enhance their agility, adaptability, and resilience in hiring workers globally. The shift toward remote work, combined with labor laws’ growing complexities across various regions, has accelerated the…
  • PEAK Matrix®
    Sep. 30, 2025

    Enterprises are increasingly turning to modern Order-to-Cash (O2C) products in response to growing cost pressures, tighter regulations, and the need for improved agility. Once viewed as a back-office finance function, O2C is becoming a strategic enabler…
  • State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    Nov. 19, 2025

    Veeva has become a cornerstone in life sciences digital transformation, offering cloud-based platforms across clinical, regulatory, safety, quality, and commercial functions. As enterprises increasingly adopt Veeva’s vault-based applications and scale global deployments, the demand for specialized…
  • PEAK Matrix®
    Aug. 26, 2026

    Order-to-Cash (O2C) is moving higher on the CFO agenda as enterprises seek to improve cash predictability, support evolving monetization models, and meet rising expectations for seamless stakeholder experiences. These priorities are accelerating demand for O2C products…
  • PEAK Matrix®
    Nov. 25, 2025

    With global and adaptive clinical trials’ rising complexities, life sciences organizations are increasingly adopting intelligent Randomization and Trial Supply Management (RTSM) platforms to enhance operational efficiency, ensure regulatory compliance, and safeguard patient integrity. RTSM systems have…
  • Technology Application Deep Dive
    April 23, 2026

    Digital Therapeutics (DTx) represent a rapidly evolving class of evidence-based interventions that leverage software as a medical device to prevent, manage, or treat medical conditions through behavioral modification, personalized feedback, and continuous data-driven support. Unlike general…
  • R&D Strategic Technology Outlook
    July 31, 2026

    This report examines optically encoded systems as enabling infrastructure for discovery science workflows across chemicals and materials Research and Development (R&D). It explains how optical encoding makes candidate libraries identifiable at scale and turns materials discovery…
  • Provider Compendium
    Feb. 28, 2025

    Decentralized and hybrid designs add more complexity to clinical trials, generating vast data volumes from diverse sources. This complexity creates significant data management challenges. In response, sponsors are adopting unified clinical Data and Analytics (D&A) platforms…
  • PEAK Matrix®
    July 31, 2025

    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments,…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • PEAK Matrix®
    Nov. 07, 2024

    Life sciences companies must engage customers effectively to drive business success through differentiated experiences. Hybrid commercial models require seamless, personalized interactions across channels to serve healthcare providers and patients. Advanced Customer Engagement Platforms (CEPs) go beyond…
  • PEAK Matrix®
    Nov. 13, 2025

    As cloud costs grow more dynamic and AI use proliferates, FinOps is evolving from cost reporting to a broader operating model that blends granular cost/usage analytics with governance and policy management, AI-powered automation, sustainability/carbon tracking, and…
  • Provider Compendium
    Dec. 17, 2025

    Life sciences organizations are increasingly prioritizing automation, configurability, and real-time visibility to support modern clinical trial requirements. As adaptive designs, decentralized models, and global multi-protocol studies become more prevalent, the role of Randomization and Trial Supply…
  • PEAK Matrix®
    Nov. 12, 2024

    Due to decentralized and hybrid designs, the growing clinical trial complexity generates vast data volumes from diverse sources and creates significant data management challenges. In response, sponsors are increasingly employing unified clinical data and analytics (D&A)…
  • Provider Compendium
    Aug. 19, 2025

    Life sciences enterprises are reassessing how they engage with healthcare professionals and patients amid growing emphasis on hybrid commercial models and personalized experiences. This shift is prompting greater interest in next-generation Customer Engagement Platforms (CEPs) that…
  • PEAK Matrix®
    Sep. 01, 2025

    eCOA solutions are transforming clinical trials by enabling accurate, real-time capture of patient, clinician, and caregiver-reported outcomes through smartphones, tablets, web portals, and provisioned devices. These platforms are redefining how clinical trials capture participant-reported data by…
  • Voice of the Customer
    Dec. 18, 2025

    AI- and automation-enabled workflows, advanced data and analytics capabilities, and increasingly interoperable technology stacks are rapidly and meaningfully transforming the pharma platforms landscape. Together, these shifts are enabling greater efficiency, scalability, and agility across the biopharma…

Items per page